MONURIL

This brand name is authorized in Austria, Brazil, Estonia, France, Ireland, Italy, Lithuania, Malta, Netherlands, Tunisia, United Kingdom, South Africa

Active ingredients

The drug MONURIL contains one active pharmaceutical ingredient (API):

1 Fosfomycin UNII 2N81MY12TE - FOSFOMYCIN

Fosfomycin exerts a bactericidal effect on proliferating pathogens by preventing the enzymatic synthesis of the bacterial cell wall. Fosfomycin inhibits the first stage of intracellular bacterial cell wall synthesis by blocking peptidoglycan synthesis. Read about Fosfomycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MONURIL Granules for oral solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01XX01	Fosfomycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XX Other antibacterials
Discover more medicines within J01XX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 533801001135411, 533815020007803
Country: EE	Ravimiamet	Identifier(s): 1607880, 1642126, 1770005, 1773873
Country: FR	Base de données publique des médicaments	Identifier(s): 67951706, 67972426
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 329828, 387731, 398343
Country: IE	Health Products Regulatory Authority	Identifier(s): 19325
Country: IT	Agenzia del Farmaco	Identifier(s): 025680024
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1092925, 1092926
Country: MT	Medicines Authority	Identifier(s): AA1116/00101, AA908/20701
Country: NL	Z-Index G-Standaard	Identifier(s): 13722409
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 30724
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 2983011
Country: ZA	Health Products Regulatory Authority	Identifier(s): 55/20.1.1/0357